Inventor · disambiguated record
Philip Erna H. Heyns
Also filed as: HEYNS PHILIP ERNA H · HEYNS PHILIP ERNA HORTENTIA GILBERT
9 granted patents·15 pending applications·39 citations·filing 2011–2024
88Inventor score
Files withALLERGAN HOLDINGS UNLIMITED COMPANY8JANSSEN PHARMACEUTICA NV6JANSSEN SCIENCES IRELAND UNLIMITED CO3DELAET URBAIN ALFONS C2TARIS BIOMEDICAL LLC2
Top patents by PatentIndex Score
24 records- 0195US11160792B2Opioid receptor modulator dosage formulationsALLERGAN HOLDINGS UNLIMITED COMPANY·Filed 2021·Granted Nov 2, 2021·4 cites·28 claims
- 0295US11090291B2Opioid receptor modulator dosage formulationsALLERGAN HOLDINGS UNLIMITED COMPANY·Filed 2021·Granted Aug 17, 2021·5 cites·24 claims
- 0395US11007179B2Opioid receptor modulator dosage formulationsALLERGAN HOLDINGS UNLIMITED COMPANY·Filed 2020·Granted May 18, 2021·5 cites·30 claims
- 0494US11229627B1Opioid receptor modulator dosage formulationsALLERGAN HOLDINGS UNLIMITED COMPANY·Filed 2021·Granted Jan 25, 2022·3 cites·30 claims
- 0594US10188632B2Opioid receptor modulator dosage formulationsALLERGAN HOLDINGS UNLIMITED COMPANY·Filed 2017·Granted Jan 29, 2019·8 cites·15 claims
- 0693US11311516B2Opioid receptor modulator dosage formulationsALLERGAN HOLDINGS UNLIMITED COMPANY·Filed 2021·Granted Apr 26, 2022·2 cites·30 claims
- 0790US11484527B2Opioid receptor modulator dosage formulationsALLERGAN HOLDINGS UNLIMITED COMPANY·Filed 2021·Granted Nov 1, 2022·1 cites·6 claims
- 0889US9675587B2Opioid receptor modulator dosage formulationsFURIEX PHARMACEUTICALS·Filed 2013·Granted Jun 13, 2017·11 cites·17 claims
- 0969US2023302024A1Darunavir combination formulationsJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2023·Application pending·0 cites
- 1066US11654150B2Darunavir combination formulationsJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2019·Granted May 23, 2023·0 cites·12 claims
- 1163US2025041574A1Erdafitinib formulations and osmotic systems for intravesical administrationTARIS BIOMEDICAL LLC·Filed 2024·Application pending·0 cites
- 1262US2021244749A1Darunavir formulationsJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2021·Application pending·0 cites
- 1360US2023226080A1Treatments of prostate cancer with combinations of abiraterone acetate and niraparibJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 1460US2023226081A1Pharmaceutical formulations of abiraterone acetate and niraparibJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 1560US2023218640A1Treatment of prostate cancer with a combination of abiraterone acetate and niraparibJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 1654US2024350485A1Erdafitinib formulations and systems for intravesical administrationTARIS BIOMEDICAL LLC·Filed 2022·Application pending·0 cites
- 1752US2016113949A1Darunavir formulationsJANSSEN R&D IRELAND·Filed 2016·Application pending·0 cites
- 1851US2014302137A1Formulation for co-therapy treatment of diabetesJANSSEN PHARMACEUTICA NV·Filed 2014·Application pending·0 cites
- 1950US2022016034A1Opioid receptor modulator dosage formulationsALLERGAN HOLDINGS UNLIMITED COMPANY·Filed 2020·Application pending·0 cites
- 2045US2014142174A1Darunavir formulationsDELAET URBAIN ALFONS C·Filed 2012·Application pending·0 cites
- 2142US2014142070A1Darunavir combination formulationsDELAET URBAIN ALFONS C·Filed 2012·Application pending·0 cites
- 2241US2019314285A1Dosage forms comprising abiraterone acetateJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 2341US2015342926A1Formulation for co-therapy treatment of diabetesJANSSEN PHARMACEUTICA NV·Filed 2015·Application pending·0 cites
- 2441US2012009259A1Formulation for co-therapy treatment of diabetesDELAET URBAIN ALFONS CLEMENTINA·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Philip Erna H. Heyns files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →